Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000017

Options or other derivatives

  • Chief Executive Officer acquired 171,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FOUSE JACQUALYN A · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-02-14 Grant or award : show line 1 in the form Stock option (right to buy) +137,000 137,000 D
2020-02-14 Grant or award : show line 2 in the form Restricted stock units +34,000 34,000 D
Loading xslF345X03/wf-form4_158214915116382.xml…